Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.40 |
| ▸ | NPFFR1 | Q9GZQ6 | 3/20 | 0.38 |
| ▸ | NPFFR2 | Q9Y5X5 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 5/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.36 |
| ▸ | MITF | O75030 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4333009 | 0.93 | PTPN1 (0.51) | PTPN1ALDH1A1KDM4EMEN1LMNA | |
| SCHEMBL4326297 | 0.83 | KDM4E (0.42) | ALDH1A1KDM4EMEN1LMNAKMT2A | |
| SCHEMBL4344446 | 0.83 | PTPN1 (0.51) | PTPN1ALDH1A1KDM4EMEN1LMNA | |
| SCHEMBL4451545 | 0.81 | PTPN1 (0.50) | PTPN1ALDH1A1KDM4EMEN1LMNA | |
| SCHEMBL4331665 | 0.78 | KMT2A (0.56) | ALDH1A1KDM4EMEN1LMNAKMT2A | |
| SCHEMBL4331661 | 0.78 | KMT2A (0.56) | ALDH1A1KDM4EMEN1LMNAKMT2A | |
| SCHEMBL4324299 | 0.78 | PTPN1 (0.56) | PTPN1ALDH1A1KDM4EMEN1LMNA | |
| SCHEMBL4324292 | 0.78 | PTPN1 (0.56) | PTPN1ALDH1A1KDM4EMEN1LMNA | |
| SCHEMBL4341378 | 0.77 | MAPT (0.48) | ALDH1A1KDM4EMEN1LMNAKMT2A | |
| SCHEMBL4343385 | 0.76 | ALDH1A1 (0.69) | PTPN1ALDH1A1KDM4EMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090285849-A1 | Thiosemicarbazones as anti-virals and immunopotentiators | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2009-11-19 | — | — | US | disclosed |
| US-7521062-B2 | Thiosemicarbazones as anti-virals and immunopotentiators | NOVARTIS VACCINES & DIAGNOSTICS, INC. (US) | 2009-04-21 | — | — | US | disclosed |
| US-20050069555-A1 | Thiosemicarbazones as anti-virals and immunopotentiators | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2005-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090285849-A1 | Thiosemicarbazones as anti-virals and immunopotentiators | MAVS, IRF3, HAVCR2 | PTPN1 476/4885ALDH1A1 1459/4885KDM4E 3010/4885 |
| US-20050069555-A1 | Thiosemicarbazones as anti-virals and immunopotentiators | MAVS, IRF3, HAVCR2 | PTPN1 525/4885ALDH1A1 1173/4885KDM4E 2338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.